Renalytix (RTNXF)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	909.00 k	909.00 k	909.00 k	909.00 k	909.00 k	909.00 k
Cash burn (monthly)	1.26 mm	1.08 mm	1.58 mm	2.35 mm	1.28 mm	2.04 mm
Cash used (since last report)	3.54 mm	3.05 mm	4.44 mm	6.62 mm	3.60 mm	5.74 mm
Cash remaining	-2.63 mm	-2.14 mm	-3.53 mm	-5.71 mm	-2.69 mm	-4.83 mm
Runway (months of cash)	-2.1	-2.0	-2.2	-2.4	-2.1	-2.4

Beta Read what these cash burn values mean

Financial data from Renalytix earnings reports.

Institutional ownership, Q2 2024

RTNXF institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	17	26	-34.6%
Opened positions	4	20	-80.0%
Closed positions	13	1	+1200.0%
Increased positions	4	2	+100.0%
Reduced positions	4	2	+100.0%

13F shares	Current	Prev Q	Change
Total value	310.46 mm	2.78 bn	-88.8%
Total shares	241.22 mm	149.73 mm	+61.1%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
School Of Medicine At Mount Sinai Icahn	222.87 mm	$0.00	+72.4%
CVI Investments	8.55 mm	$7.35 mm	0.0%
Jefferson River Capital	8.53 mm	$8.53 mm	0.0%
Pinnacle Associates	815.43 k	$188.36 mm	+17.2%
Nantahala Capital Management	117.64 k	$27.18 mm	0.0%
Cantor Fitzgerald, L. P.	115.00 k	$26.57 mm	NEW
Wealth Enhancement Advisory Services	63.74 k	$14.72 mm	0.0%
Traynor Capital Management	60.00 k	$13.86 mm	NEW
CVI	38.35 k	$8.86 mm	NEW
Two Sigma Securities	24.68 k	$5.70 mm	+5.8%

Largest transactions	Shares	Bought/sold	Change
School Of Medicine At Mount Sinai Icahn	222.87 mm	+93.60 mm	+72.4%
Gilder Gagnon Howe & Co	0.00	-761.11 k	EXIT
SF Stifel Financial	0.00	-558.40 k	EXIT
Tejara Capital	0.00	-500.39 k	EXIT
CI Private Wealth	0.00	-335.51 k	EXIT
Lazard Asset Management	681.00	-124.80 k	-99.5%
Pinnacle Associates	815.43 k	+119.42 k	+17.2%
Cantor Fitzgerald, L. P.	115.00 k	+115.00 k	NEW
Traynor Capital Management	60.00 k	+60.00 k	NEW
North Star Investment Management	0.00	-43.00 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

RTNXF insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
1 Nov 24	School Of Medicine At Mount Sinai Icahn	Ordinary Shares	Other	Acquire J	No	No	0.116	13,366,750	1.55 mm	32,683,998
11 Jun 24	Joel R Jung	Employee Stock Option Ordinary Shares	Grant	Acquire A	No	No	0.2067	60,000	12.40 k	60,000
24 Apr 24	School Of Medicine At Mount Sinai Icahn	Ordinary Shares	Other	Acquire J	No	No	0.25	9,360,374	2.34 mm	19,317,248
20 Nov 23	Howard Doran JR	Employee Stock Option Ordinary Shares	Grant	Acquire A	No	No	0.304	300,000	91.20 k	300,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Commencement of trading on OTCQB in the United States

8 Oct 24

LONDON and NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (OTCQB:RNLXY), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney